India-headquartered contract research, development, and manufacturing organisation Aragen (formerly GVK Biosciences) has secured $100 million in funding from healthcare-focused private equity firm Quadria Capital, the company announced on Monday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
